Matinas Biopharma Holdings Inc

Research Matinas Biopharma Holdings Inc (MTNB) on Bullrun: market cap USD 4.25M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerMTNB
• ExchangeNYSE MKT
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 4.25M
• Financial periodFY2025
• Net income-USD 10.35M

Valuation Snapshot

latest market cap is USD 4.25M.

About Matinas Biopharma Holdings Inc

Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nanocrystals for the delivery of small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides.

Frequently asked questions

What is Matinas Biopharma Holdings Inc's market cap?

Matinas Biopharma Holdings Inc's market capitalization is USD 4.25M.

What does Matinas Biopharma Holdings Inc do?

Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology.